Stay updated with breaking news from Aytu Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following the market opening Thursday, the Dow traded down 0.12% to 30,033.62 while the NASDAQ rose 0.32% to 12,378.96. The S&P also rose, gaining 0.02% to 3,673.72.
Neos Therapeutics Inc (NASDAQ: NEOS) in an all-stock merger transaction. The boards of both companies have approved the deal. Upon the closing of the merger, Neos shareholders will receive 0.1088 shares of Aytu for each share they hold in Neos, after taking into account the 1-for-10 reverse split of Aytu shares that took effect Dec. 8. The deal terms value Neos at $44.9 million. Neos shareholders will end up owning a 30% stake in Aytu. "The combined entity will have an increased footprint in the prescription pediatric market, an established, growing multi-brand ADHD portfolio addressing the...
Midway through trading Thursday, the Dow traded down 0.19% to 30,012.81 while the NASDAQ rose 0.47% to 12,396.34. The S&P also fell, dropping 0.03% to 3,671.66.
Toward the end of trading Thursday, the Dow traded down 0.41% to 29,945.74 while the NASDAQ rose 0.29% to 12,375.19. The S&P also fell, dropping 0.30% to 3,661.97.
Merger accelerates transformation to profitability, with estimated annualized cost synergies of $15M beginning FY 2022 Aytu adds Neos' established,